Invention Grant
US08952036B2 Benzoic acid derivative MDM2 inhibitor for the treatment of cancer
有权
苯甲酸衍生物MDM2抑制剂治疗癌症
- Patent Title: Benzoic acid derivative MDM2 inhibitor for the treatment of cancer
- Patent Title (中): 苯甲酸衍生物MDM2抑制剂治疗癌症
-
Application No.: US14192553Application Date: 2014-02-27
-
Publication No.: US08952036B2Publication Date: 2015-02-10
- Inventor: Yosup Rew
- Applicant: Amgen Inc.
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Joseph W. Bulock; Todd M. Crissey
- Main IPC: A61K31/45
- IPC: A61K31/45 ; C07D211/76
Abstract:
The present invention provides a MDM2 inhibitor compound, or a pharmaceutically acceptable salt thereof, which compound is useful as a therapeutic agent, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contains the MDM2 inhibitor.
Public/Granted literature
- US20140243372A1 BENZOIC ACID DERIVATIVE MDM2 INHIBITOR FOR THE TREATMENT OF CANCER Public/Granted day:2014-08-28
Information query
IPC分类:
